{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:48:33Z","timestamp":1782449313642,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kaohsiung Medical University Hospital, Taiwan"},{"name":"Kaohsiung Medical University Gangshan Hospital"},{"name":"NSYSU-KMU Joint Research Project, Taiwan"},{"name":"National Science and Technology Council, Taiwan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05270-z","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:43:13Z","timestamp":1779763393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring XDH expression as a prognostic marker for urothelial carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Meng-Yun","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Lung","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yow-Ling","family":"Shiue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Chih","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"5270_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"Cancer J Clin"},{"issue":"19","key":"5270_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. Jama. 2020;324(19):1980\u201391.","journal-title":"Jama"},{"issue":"1","key":"5270_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"1","key":"5270_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comperat EM, Cowan NC, Gakis G, Hernandez V, Linares Espinos E, Lorch A, Neuzillet Y, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"1","key":"5270_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupret","year":"2021","unstructured":"Roupret M, Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62\u201379.","journal-title":"Eur Urol"},{"issue":"12","key":"5270_CR6","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.3390\/jcm9123866","volume":"9","author":"LC Yu","year":"2020","unstructured":"Yu LC, Chang CH, Huang CP, Huang CY, Hong JH, Tai TY, Weng HY, Lo CW, Tsai CY, Lee YK et al. Prognostic significance of primary tumor location in upper tract urothelial carcinoma treated with nephroureterectomy: a retrospective, multi-center cohort study in Taiwan. J Clin Med 2020, 9(12):3866.","journal-title":"J Clin Med"},{"issue":"10","key":"5270_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","volume":"24","author":"J Miyazaki","year":"2017","unstructured":"Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urol. 2017;24(10):730\u20134.","journal-title":"Int J Urol"},{"issue":"6","key":"5270_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"7492","key":"5270_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315\u201322.","journal-title":"Nature"},{"issue":"6","key":"5270_CR10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.euf.2020.08.001","volume":"7","author":"A Necchi","year":"2021","unstructured":"Necchi A, Madison R, Pal SK, Ross JS, Agarwal N, Sonpavde G, Joshi M, Yin M, Miller VA, Grivas P, et al. Comprehensive genomic profiling of upper-tract and bladder urothelial carcinoma. Eur Urol focus. 2021;7(6):1339\u201346.","journal-title":"Eur Urol focus"},{"key":"5270_CR11","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","volume":"9","author":"J Yin","year":"2018","unstructured":"Yin J, Ren W, Huang X, Deng J, Li T, Yin Y. Potential mechanisms connecting purine metabolism and cancer therapy. Front Immunol. 2018;9:1697.","journal-title":"Front Immunol"},{"issue":"9","key":"5270_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/cancers11091354","volume":"11","author":"M Camici","year":"2019","unstructured":"Camici M, Garcia-Gil M, Pesi R, Allegrini S, Tozzi MG. Purine-metabolising enzymes and apoptosis in cancer. Cancers 2019; 11(9):1354.","journal-title":"Cancers"},{"issue":"6","key":"5270_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/21655979.2016.1206168","volume":"7","author":"CH Wang","year":"2016","unstructured":"Wang CH, Zhang C, Xing XH. Xanthine dehydrogenase: an old enzyme with new knowledge and prospects. Bioengineered. 2016;7(6):395\u2013405.","journal-title":"Bioengineered"},{"key":"5270_CR14","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti M, Polito L, Battelli MG, Bolognesi A. Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol. 2021;41:101882.","journal-title":"Redox Biol"},{"key":"5270_CR15","doi-asserted-by":"publisher","first-page":"101070","DOI":"10.1016\/j.redox.2018.101070","volume":"21","author":"MG Battelli","year":"2019","unstructured":"Battelli MG, Bortolotti M, Polito L, Bolognesi A. Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase. Redox Biol. 2019;21:101070.","journal-title":"Redox Biol"},{"issue":"3","key":"5270_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cam4.601","volume":"5","author":"MG Battelli","year":"2016","unstructured":"Battelli MG, Polito L, Bortolotti M, Bolognesi A. Xanthine oxidoreductase in cancer: more than a differentiation marker. Cancer Med. 2016;5(3):546\u201357.","journal-title":"Cancer Med"},{"issue":"2","key":"5270_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2010.03.024","volume":"49","author":"M Romagnoli","year":"2010","unstructured":"Romagnoli M, Gomez-Cabrera MC, Perrelli MG, Biasi F, Pallardo FV, Sastre J, Poli G, Vina J. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic Biol Med. 2010;49(2):171\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5270_CR18","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1038\/oncsis.2017.81","volume":"6","author":"GL Chen","year":"2017","unstructured":"Chen GL, Ye T, Chen HL, Zhao ZY, Tang WQ, Wang LS, Xia JL. Xanthine dehydrogenase downregulation promotes TGFbeta signaling and cancer stem cell-related gene expression in hepatocellular carcinoma. Oncogenesis. 2017;6(9):e382.","journal-title":"Oncogenesis"},{"issue":"6","key":"5270_CR19","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/hep.30978","volume":"71","author":"Q Sun","year":"2020","unstructured":"Sun Q, Zhang Z, Lu Y, Liu Q, Xu X, Xu J, Liu Y, Yu H, Yu D, Sun B. Loss of xanthine oxidoreductase potentiates propagation of hepatocellular carcinoma stem cells. Hepatology. 2020;71(6):2033\u201349.","journal-title":"Hepatology"},{"issue":"9","key":"5270_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jcp.2005.032524","volume":"59","author":"N Linder","year":"2006","unstructured":"Linder N, Haglund C, Lundin M, Nordling S, Ristimaki A, Kokkola A, Mrena J, Wiksten JP, Lundin J. Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer. J Clin Pathol. 2006;59(9):965\u201371.","journal-title":"J Clin Pathol"},{"issue":"12","key":"5270_CR21","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1158\/1078-0432.CCR-04-2280","volume":"11","author":"N Linder","year":"2005","unstructured":"Linder N, Lundin J, Isola J, Lundin M, Raivio KO, Joensuu H. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin Cancer Res. 2005;11(12):4372\u201381.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5270_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/jcb.21901","volume":"105","author":"MA Fini","year":"2008","unstructured":"Fini MA, Orchard-Webb D, Kosmider B, Amon JD, Kelland R, Shibao G, Wright RM. Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. J Cell Biochem. 2008;105(4):1008\u201326.","journal-title":"J Cell Biochem"},{"issue":"5","key":"5270_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","volume":"18","author":"M Riester","year":"2012","unstructured":"Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, Bochner BH, Michor F. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res. 2012;18(5):1323\u201333.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"5270_CR24","doi-asserted-by":"publisher","first-page":"7650","DOI":"10.1158\/1078-0432.CCR-17-0002","volume":"23","author":"CF Li","year":"2017","unstructured":"Li CF, Wu WR, Chan TC, Wang YH, Chen LR, Wu WJ, Yeh BW, Liang SS, Shiue YL. Transmembrane and coiled-coil domain 1 impairs the AKT signaling pathway in urinary bladder urothelial carcinoma: a characterization of a tumor suppressor. Clin Cancer Res. 2017;23(24):7650\u201363.","journal-title":"Clin Cancer Res"},{"key":"5270_CR25","doi-asserted-by":"publisher","first-page":"635774","DOI":"10.3389\/fonc.2021.635774","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Qin X, Liang J, Ge P. Induction of pyroptosis: a promising strategy for cancer treatment. Front Oncol. 2021;11:635774.","journal-title":"Front Oncol"},{"issue":"5","key":"5270_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrc3051","volume":"11","author":"RL Dusek","year":"2011","unstructured":"Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer. 2011;11(5):317\u201323.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"5270_CR27","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.bbadis.2014.05.022","volume":"1842","author":"MG Battelli","year":"2014","unstructured":"Battelli MG, Bolognesi A, Polito L. Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. Biochim Biophys Acta. 2014;1842(9):1502\u201317.","journal-title":"Biochim Biophys Acta"},{"key":"5270_CR28","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1038\/ncomms7555","volume":"6","author":"A Ives","year":"2015","unstructured":"Ives A, Nomura J, Martinon F, Roger T, LeRoy D, Miner JN, Simon G, Busso N, So A. Xanthine oxidoreductase regulates macrophage IL1beta secretion upon NLRP3 inflammasome activation. Nat Commun. 2015;6:6555.","journal-title":"Nat Commun"},{"issue":"2","key":"5270_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.atherosclerosis.2014.10.006","volume":"237","author":"MG Battelli","year":"2014","unstructured":"Battelli MG, Polito L, Bolognesi A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis. 2014;237(2):562\u20137.","journal-title":"Atherosclerosis"},{"issue":"3","key":"5270_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11357-997-0012-2","volume":"20","author":"HY Chung","year":"1997","unstructured":"Chung HY, Baek BS, Song SH, Kim MS, Huh JI, Shim KH, Kim KW, Lee KH. Xanthine dehydrogenase\/xanthine oxidase and oxidative stress. Age. 1997;20(3):127\u201340.","journal-title":"Age"},{"issue":"6","key":"5270_CR31","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M, Bohle A, Burger M, Comperat EM, Cowan NC, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol. 2016;70(6):1052\u201368.","journal-title":"Eur Urol"},{"key":"5270_CR32","doi-asserted-by":"publisher","first-page":"100310","DOI":"10.1016\/j.jlb.2025.100310","volume":"9","author":"F Crocetto","year":"2025","unstructured":"Crocetto F, Amicuzi U, Musone M, Magliocchetti M, Di Lieto D, Tammaro S, Pastore AL, Fuschi A, Falabella R, Ferro M, Bianchi R, Finati M, Busetto GM, Lucarelli G, Del Giudice F, Caputo VF, Balsamo R, Terracciano D. Liquid biopsy: current advancements in clinical practice for bladder cancer. J Liquid Biopsy. 2025;9:100310.","journal-title":"J Liquid Biopsy"},{"issue":"10","key":"5270_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.urolonc.2025.07.034","volume":"43","author":"P Pisapia","year":"2025","unstructured":"Pisapia P, Pepe F, Russo G, Capoluongo R, Coppola M, Giudice FD, Ferro M, Madonna A, Musone M, Troncone G, Malapelle U, Crocetto F. Liquid biopsy testing in urological cancers: focus on urine. Urololic Oncol. 2025;43(10):553\u201364.","journal-title":"Urololic Oncol"},{"issue":"5","key":"5270_CR34","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1073\/pnas.96.5.2396","volume":"96","author":"D Hersh","year":"1999","unstructured":"Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 1999;96(5):2396\u2013401.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"5270_CR35","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1111\/j.1462-5822.2007.01036.x","volume":"9","author":"SL Fink","year":"2007","unstructured":"Fink SL, Cookson BT. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol. 2007;9(11):2562\u201370.","journal-title":"Cell Microbiol"},{"issue":"7237","key":"5270_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514\u20138.","journal-title":"Nature"},{"issue":"9","key":"5270_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27(9):673\u201384.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"5270_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"10","key":"5270_CR39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, Nie L, Chen Y, Wang YC, Liu C, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22(10):1264\u201375.","journal-title":"Nat Cell Biol"},{"issue":"7521","key":"5270_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187\u201392.","journal-title":"Nature"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05270-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05270-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05270-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:17:26Z","timestamp":1782447446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05270-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5270"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05270-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Chi Mei Medical Center (Approval No. 10501-005). All procedures involving human data were conducted in accordance with institutional ethical standards and the principles of the Declaration of Helsinki. Patient-informed consent was obtained in accordance with the procedures approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"937"}}